Pain management practices have an especially high legal risk due to the many requirements for prescribing controlled substances and to large potential money damages for pain control malpractice.
This course covers topics such as prescribing and storing controlled substances, chronic pain management, and fraudulent or excessive prescriptions. For a complete list of this program’s content, see below.
Now, for a special discounted fee, you can attend one day specifically devoted to pain management (Saturday) out of the Western Institute’s 2 1/2 day long Prescribing Practices and Management of Pain and Substance Abuse Disorder course.
The course fee ($600) is insignificant compared to the high cost of one criminal prosecution, one licensing board accusation, or one malpractice lawsuit. Let us help you adjust your procedures to minimize the legal risks of your pain management practice.
Note: WILM’s 1-day Pain Management course does NOT meet the requirements for physician probation in CA
1 day program
This includes an 80+ page fully-indexed syllabus.
8:30 AM – 12:30 PM PST
1:30 PM – 5:30 PM PST
Due to COVID-19 all WILM Ed courses are currently held online via Zoom conferencing software and can only be attended remotely. You must have a computer, internet access, video and audio capabilities and browser software in order to participate.
This is one day specifically devoted to pain management out of the Western Institute’s 2 1/2 day long Prescribing Practices and Management of Pain and Substance Abuse Disorder course. Physicians will be awarded CME hours for the number of hours actually attended (in this case 7 hours). Please see the CME Accreditation statement from the Western Institute’s Prescribing Practices and Management of Pain and Substance Abuse Disorder course.
The statements and opinions contained in this program are solely those of the individual authors and contributors and not of the WILM Programs. The appearance of the advertisements is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The content of this presentation and publication may contain discussion of off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses. The WILM Programs disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the presentation or advertisements.